Tendon, ligament, cartilage, bone and joint recovery — what the evidence really shows.
Injuries & Orthopedics is the musculoskeletal hub — tendon, ligament, cartilage, bone and joint recovery, the highest-search, highest-intent peptide cluster. It is also where the gap between promise and proof is widest: the most popular repair peptides are backed mostly by animal studies. We cover the mechanisms, the real evidence grade, and the anti-doping reality for athletes.
Thymosin beta-4 (RGN-259) is the rare peptide with real, large human RCTs for the ocular surface — yet every pivotal Phase 3 missed its co-primary endpoint. A clinical-editorial ranking of what the dry-eye evidence actually supports in 2026.
A clinical, evidence-first look at the peptides pitched for lateral and medial epicondylitis — BPC-157 and TB-500/thymosin β-4 — and why both are graded C (preclinical only) for the elbow.
Injuries & OrthopedicsAn evidence-graded review of the peptides marketed for cartilage and meniscus repair. The honest 2026 verdict: no peptide has a placebo-controlled human trial showing cartilage regrowth or meniscus repair, and the only controlled human data belongs to pentosan polysulfate — which is not even a peptide.
Injuries & OrthopedicsLL-37, GHK-Cu, thymosin β4/TB-500 and BPC-157 all have real wound-healing biology — but not a single controlled human burn trial. A clinical-editorial ranking of what the evidence actually supports in 2026.
Injuries & OrthopedicsA clinical, evidence-ranked look at the peptides marketed for back injury, spinal soft-tissue repair, and disc health — what the published data actually supports, and what is marketing.
Injuries & OrthopedicsAn evidence-graded review of the peptides marketed for athletic recovery — BPC-157, ipamorelin, CJC-1295 and TB-500. The honest 2026 verdict: every one is Grade C or D for recovery as an outcome, none is FDA-approved, and all are WADA-banned at all times.
Injuries & OrthopedicsAn evidence-graded review of the peptides marketed for ankle sprains, ATFL tears and Achilles injury. The honest 2026 verdict: no human RCT exists; the strongest case is preclinical (rat Achilles models), and PRP — not a peptide — has the better human ankle evidence.
The honest answer is that the evidence is almost entirely preclinical. Peptides such as BPC-157 and TB-500 show consistent tendon, ligament and muscle-healing effects in rodent models, with coherent mechanisms involving angiogenesis and cell migration. But there are no completed human randomized controlled trials demonstrating they heal injuries in people — the first such trial only recently began. We grade these compounds C (preclinical only) and are explicit that human healing claims extrapolate from animal data.
Most are not FDA-approved and exist in a regulatory gray zone. Several were placed on the FDA 503A Category 2 list in 2023, removed in April 2026 because the nominations were withdrawn (not because they were found safe), and are scheduled for advisory-committee review in July 2026 — none of which authorizes compounding. They are sold as "research chemicals not for human use." Legal status changes; we date-stamp every regulatory statement and link the primary source.
Athletes face a specific, serious risk: many tissue-repair peptides, including BPC-157 and TB-500, are prohibited at all times under the WADA Prohibited List (category S0, non-approved substances), with no therapeutic use exemption available. They are detectable in testing and have triggered real sanctions and bans. The NFL, UFC and US Department of Defense also prohibit them. Any WADA-tested or military athlete should treat these compounds as banned.
The majority of compounds documented here are not approved by the FDA for human use. Approved drugs (e.g. semaglutide, tirzepatide) are noted explicitly and require a licensed prescriber.
Many peptides — including BPC-157 and GHK-Cu in injectable form — are sold strictly "for research use only — not for human consumption." Purity, identity, and dosing of such products are not regulated or guaranteed.
Several compounds are banned in competitive sport under the WADA Prohibited List. Athletes risk sanction regardless of intent or formulation.
Always consult a qualified, licensed healthcare professional before considering any compound. Individual risk depends on your full medical context.
This content is for informational and educational purposes only · No physician–patient relationship is created · Evidence grades reflect published data as of the stated revision and may change.
